维普中文期刊产品整合服务
134篇 您的检索式:作者名="Burnier M"
    题名 作者 年代 出处 被引量
1Treatment of essential hy- pertension with calcium channel blockers:what is the place of lercanidipine 显示文摘Burnier M Pruijm M Wuerzner G 2009Expert Opin Drag Metab Toxicol2009,8,5:1
2Medication adherence and persistence as the cornerstone of effective antihypertensive therapy显示文摘Burnier M 2006Am J Hypertens2006,19,11:1
3Body mass index,abdominal adiposity,and blood pressure:Consistencey of their association across developing and developed countries显示文摘Doll S Paccaud F Burnier M 2002Int J Obes Relat Metab Disord2002,26,:1
4Circadian variations in blood pressure: Im- plications for chronotherapeutics显示文摘Hassler C Burnier M 2005Am J Cardiovase Drugs2005,5,1:1
5Telmisartan/hydrochlorothiazide: a new fixed dose combination 显示文摘MAILLARD M BURNIER M 2005Expert Rev Cardiovasc Ther2005,3,3:1
6Comparative safety and tolerability of angiotension Ⅱ receptor antagonists显示文摘 Burnier M 1999Drug Safety1999,21,:1
7Hypertension therapy in pa-tients with renal artery stenosis显示文摘Vogt B Maillard M Burnier M 2012Ther Umsch2012,69,5:1
8Blockade of the rennin-angiotesinaldosterone system:A key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes显示文摘Burnier M Zanchi A 2006J Hypertens2006,24,1:1
9Pharmacokinetic and pharmacodynarnic effects of YM087,a combined V1/V2 vasopressin receptor antagonist in normal subjects显示文摘Burnier M Fricker AF Hayoz D 1999Eur J Clin Pharmacol1999,55,9:1
10Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?显示文摘MAILLARD MP BURNIER M 2007Vasc Health Risk Manag2007,3,3:1
11Vascular endothelial growth factor expression and inhibition in uveal melanoma cell lines显示文摘Logan P Burnier J Burnier M N Jr 0,,336:1
12Angiotensin II type 1 receptor blockers显示文摘Burnier M 2001Circula-tion2001,103,:1
13Renal effects of angiotensin Ⅱ receptor blockade in normotensive subjects 显示文摘Burnier M Roch RF 1996Kidney Int1996,49,6:1
14Short-term and sustained renal effects of angiotensin ll receptor blockade in healthy subjects显示文摘Burnier M Hagman M Nussberger J 1995Hypertension1995,25,1:1
15Nutrition in cardiovascular dis- ease: salt in hypertension and heart failure显示文摘He F J Burnier M Macgregor G A 2011Eur Heart J2011,32,24:1
16How to improve adherence with prescribed treatment in hypertensive patients?显示文摘Waeber B Burnier M Brunner HR 2000J Cardiovasc Phar- macol2000,35,3:1
17Electronic compliance monitoring in resistant hypertension:the bans for rational therapeatic decisions 显示文摘Burnier M Schneider MP Chiol e ro A etal 2001J hypertens2001,19,3:1
18Female sex hormones, salt, and blood pressure regulation显示文摘Pechere-Bertschi A Burnier M 2004Am J Hypertens2004,17,10:1
19P:ole of Gas6 receptors in platelet signaling during thrembus stabilization and implications for antithrombotic therapy显示文摘An6elille-Scherrer A Burnier L Flores N et M 2005J Olin Invest2005,116,2:1
20Angiotensin II receptor antagonists显示文摘M Burnier HR Brunner 2000The Lancet2000,,9204:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费